Citation 149853

CASTRILLO,A: DE LAS HERAS,B: HORTELANO,S: RODRIGUEZ,B: VILLAR,A: BOSCA,L:. (2001). INHIBITION OF THE NUCLEAR FACTOR GAMMA-B (NF-GAMMA-B) PATHWAY BY TETRACYCLIC KAURENE DITERPENES IN MACROPHAGES.. 276(19)

Citation Details

Title	INHIBITION OF THE NUCLEAR FACTOR GAMMA-B (NF-GAMMA-B) PATHWAY BY TETRACYCLIC KAURENE DITERPENES IN MACROPHAGES.
Authors	CASTRILLO,A: DE LAS HERAS,B: HORTELANO,S: RODRIGUEZ,B: VILLAR,A: BOSCA,L:
Year	2001
Volume	276
Issue	19

Summary

Year: 2001

Journal: Unknown

Organisms and Their Experiments (1)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	NUCLEAR FACTOR KAPPA-BETA INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FOLIOL	INACTIVE
2	I-KAPPA-B KINASE 2 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FOLIOL	ACTIVE
3	TUMOR NECROSING FACTOR-ALPHA RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FOLIOL	ACTIVE
4	NITRIC OXIDE SYNTHASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FOLIOL	ACTIVE
5	NITRIC OXIDE SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FOLIOL	ACTIVE
6	NUCLEAR FACTOR KAPPA-BETA INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FOLIOL	ACTIVE
7	PHOSPHORYLATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FOLIOL	ACTIVE
8	NITRIC OXIDE SYNTHASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LINEAROL	ACTIVE
9	NITRIC OXIDE SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LINEAROL	ACTIVE
10	NUCLEAR FACTOR KAPPA-BETA INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LINEAROL	ACTIVE
11	NUCLEAR FACTOR KAPPA-BETA INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LINEAROL	INACTIVE
12	I-KAPPA-B KINASE 2 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LINEAROL	ACTIVE
13	TUMOR NECROSING FACTOR-ALPHA RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LINEAROL	ACTIVE
14	PHOSPHORYLATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LINEAROL	ACTIVE
15	NITRIC OXIDE SYNTHASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KAUR-16-EN-19-OIC ACID,ENT:	ACTIVE
16	NITRIC OXIDE SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KAUR-16-EN-19-OIC ACID,ENT:	ACTIVE
17	NUCLEAR FACTOR KAPPA-BETA INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KAUR-16-EN-19-OIC ACID,ENT:	ACTIVE
18	NUCLEAR FACTOR KAPPA-BETA INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KAUR-16-EN-19-OIC ACID,ENT:	INACTIVE
19	I-KAPPA-B KINASE 2 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KAUR-16-EN-19-OIC ACID,ENT:	ACTIVE
20	TUMOR NECROSING FACTOR-ALPHA RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KAUR-16-EN-19-OIC ACID,ENT:	ACTIVE
21	PHOSPHORYLATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KAUR-16-EN-19-OIC ACID,ENT:	ACTIVE
22	NITRIC OXIDE SYNTHASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	TEUCRIN A	ACTIVE
23	NITRIC OXIDE SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	TEUCRIN A	WEAK ACTIVITY
24	NITRIC OXIDE SYNTHASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GNAPHALIN,19-ACETYL:	ACTIVE
25	NITRIC OXIDE SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GNAPHALIN,19-ACETYL:	WEAK ACTIVITY
26	NITRIC OXIDE SYNTHASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ERIOCEPHALIN	ACTIVE
27	NITRIC OXIDE SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ERIOCEPHALIN	WEAK ACTIVITY

Citation 149853

Citation Details

Summary

Organisms and Their Experiments (1)

Unknown organism

Show SPARQL Queries (1)

Query 1